[HTML][HTML] Mathematical Modeling Support for Lung Cancer Therapy—A Short Review

J Smieja - International Journal of Molecular Sciences, 2023 - mdpi.com
The paper presents a review of models that can be used to describe dynamics of lung
cancer growth and its response to treatment at both cell population and intracellular …

[HTML][HTML] Polycondensed Peptide-Based Polymers for Targeted Delivery of Anti-Angiogenic siRNA to Treat Endometriosis

A Egorova, M Maretina, I Krylova, A Kiselev - International Journal of …, 2023 - mdpi.com
Endometriosis (EM) is a prevalent gynecological disease characterized by the abnormal
growth of tissue similar to the endometrium outside of the uterus. This condition is …

[HTML][HTML] The Efficacy and Safety of Anlotinib Plus Etoposide with Cisplatin/Carboplatin in the First-Line Treatment of Lung Cancer: A Phase II Clinical Study

X Lv, Y Liu, Y Feng, H Liang, W Zhi - Journal of Cancer, 2024 - ncbi.nlm.nih.gov
Background: The primary aim of this phase II clinical study was to assess the safety and
efficacy of combining anlotinib, etoposide, and platinum-based drugs as a first-line treatment …

A graphSAGE discovers synergistic combinations of Gefitinib, paclitaxel, and Icotinib for Lung adenocarcinoma management by targeting human genes and proteins …

S Sadeghi, AA Kiaei, M Boush, N Salari… - medRxiv, 2024 - medrxiv.org
Background: Adenocarcinoma of the lung is the most common type of lung cancer, and it is
characterized by distinct cellular and molecular features. It occurs when abnormal lung cells …

Using recombinant endostatin and platinum-based radiotherapy for non-small cell lung cancer.

BK Sahu, P Verma, J Sinha - Onkologia i Radioterapia, 2023 - search.ebscohost.com
Abstract Non-small Cell Lung Cancer (NCLC) is the predominant form of lung cancer,
representing the primary cause of cancer-related mortality on a global scale. In recent …

CLL and Lymphoma Studies at EHA2021 and 16-ICML

D Rossi - healthbook TIMES Oncology …, 2021 - onco-hema.healthbooktimes.org
The myelodysplastic syndromes (MDS) represent a heterogeneous group of clonal
disorders caused by somatic driver mutations affecting the hematopoietic stem and …

[HTML][HTML] Recent Progress in Thoracic Oncology: WCLC 2023 Highlights

S Krauss - healthbook TIMES Oncology …, 2023 - onco-hema.healthbooktimes.org
The World Congress on Lung Cancer (WCLC) organized by the International Association for
the Study of Lung Cancer (IASLC) took place from September 9 to 12, 2023, in Singapore …